GrippeEspagneV1, Main, Exploration, bibRecord, 000018

TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines.

Identifieur interne : 000018 ( Main/Exploration ); précédent : 000017; suivant : 000019

TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines.

Auteurs : Federico Martin N-Torres [Espagne] ; Xavier Bosch [Espagne] ; Rino Rappuoli [Italie, Royaume-Uni] ; Shamez Ladhani [Royaume-Uni] ; Esther Redondo [Espagne] ; Timo Vesikari [Finlande] ; Adolfo García-Sastre [États-Unis] ; Irene Rivero-Calle [Espagne] ; José G Mez-Rial [Espagne] ; Antonio Salas [Espagne] ; Carlos Martín [Espagne] ; Adam Finn [Royaume-Uni] ; Robb Butler [États-Unis]

Source :

Human vaccines & immunotherapeutics [ 2164-554X ] ; 2019.

RBID : pubmed:31158041

Descripteurs français

KwdFr :
- Congrès comme sujet (MeSH), Contrôle des maladies transmissibles (MeSH), Espagne (MeSH), Essais cliniques comme sujet (MeSH), Humains (MeSH), Maladies transmissibles (parasitologie), Maladies transmissibles (virologie), Personnel de santé (MeSH), Vaccins (MeSH).
MESH :
- parasitologie : Maladies transmissibles.
- virologie : Maladies transmissibles.
- Congrès comme sujet, Contrôle des maladies transmissibles, Espagne, Essais cliniques comme sujet, Humains, Personnel de santé, Vaccins.
Wicri :
- geographic : Espagne.

English descriptors

KwdEn :
- Clinical Trials as Topic (MeSH), Communicable Disease Control (MeSH), Communicable Diseases (parasitology), Communicable Diseases (virology), Congresses as Topic (MeSH), Health Personnel (MeSH), Humans (MeSH), Spain (MeSH), Vaccines (MeSH).
MESH :
- chemical : Vaccines.
- geographic : Spain.
- parasitology : Communicable Diseases.
- virology : Communicable Diseases.
- Clinical Trials as Topic, Communicable Disease Control, Congresses as Topic, Health Personnel, Humans.

Abstract

The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22-23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.

DOI: 10.1080/21645515.2019.1609823
PubMed: 31158041
PubMed Central: PMC6816368

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 00015
to stream Main, to step Curation: 000015

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">TIPICO IX: report of the 9<sup>th</sup>
 interactive infectious disease workshop on infectious diseases and vaccines.</title>
<author><name sortKey="Martin N Torres, Federico" sort="Martin N Torres, Federico" uniqKey="Martin N Torres F" first="Federico" last="Martin N-Torres">Federico Martin N-Torres</name>
<affiliation wicri:level="1"><nlm:affiliation>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bosch, Xavier" sort="Bosch, Xavier" uniqKey="Bosch X" first="Xavier" last="Bosch">Xavier Bosch</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Epidemiology Research Programme (e-oncología), Catalan Institute of Oncology, L'Hospitalet de Llobregat , Barcelona , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Cancer Epidemiology Research Programme (e-oncología), Catalan Institute of Oncology, L'Hospitalet de Llobregat , Barcelona </wicri:regionArea>
<wicri:noRegion>Barcelona </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat , Barcelona , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat , Barcelona </wicri:regionArea>
<wicri:noRegion>Barcelona </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rappuoli, Rino" sort="Rappuoli, Rino" uniqKey="Rappuoli R" first="Rino" last="Rappuoli">Rino Rappuoli</name>
<affiliation wicri:level="1"><nlm:affiliation>R&D Centre, GlaxoSmithKline , Siena , Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>R&D Centre, GlaxoSmithKline , Siena </wicri:regionArea>
<wicri:noRegion>Siena </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Imperial College London , London , UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Medicine, Imperial College London , London </wicri:regionArea>
<wicri:noRegion>London </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ladhani, Shamez" sort="Ladhani, Shamez" uniqKey="Ladhani S" first="Shamez" last="Ladhani">Shamez Ladhani</name>
<affiliation wicri:level="1"><nlm:affiliation>Immunisation Department, Public Health England , London , UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Immunisation Department, Public Health England , London </wicri:regionArea>
<wicri:noRegion>London </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Redondo, Esther" sort="Redondo, Esther" uniqKey="Redondo E" first="Esther" last="Redondo">Esther Redondo</name>
<affiliation wicri:level="1"><nlm:affiliation>International Vaccination Center of Madrid , Madrid , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>International Vaccination Center of Madrid , Madrid </wicri:regionArea>
<wicri:noRegion>Madrid </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Grupo de Actividades Preventivas y Salud Pública SEMERGEN , Madrid , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Grupo de Actividades Preventivas y Salud Pública SEMERGEN , Madrid </wicri:regionArea>
<wicri:noRegion>Madrid </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vesikari, Timo" sort="Vesikari, Timo" uniqKey="Vesikari T" first="Timo" last="Vesikari">Timo Vesikari</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine and Life Sciences, Vaccine Research Center, University of Tampere , Tampere , Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Faculty of Medicine and Life Sciences, Vaccine Research Center, University of Tampere , Tampere </wicri:regionArea>
<wicri:noRegion>Tampere </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Garcia Sastre, Adolfo" sort="Garcia Sastre, Adolfo" uniqKey="Garcia Sastre A" first="Adolfo" last="García-Sastre">Adolfo García-Sastre</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York , NY , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York , NY </wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai , New York , NY , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai , New York , NY </wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai , New York , NY , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai , New York , NY </wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rivero Calle, Irene" sort="Rivero Calle, Irene" uniqKey="Rivero Calle I" first="Irene" last="Rivero-Calle">Irene Rivero-Calle</name>
<affiliation wicri:level="1"><nlm:affiliation>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="G Mez Rial, Jose" sort="G Mez Rial, Jose" uniqKey="G Mez Rial J" first="José" last="G Mez-Rial">José G Mez-Rial</name>
<affiliation wicri:level="1"><nlm:affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Salas, Antonio" sort="Salas, Antonio" uniqKey="Salas A" first="Antonio" last="Salas">Antonio Salas</name>
<affiliation wicri:level="1"><nlm:affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, of the Instituto de Investigación Sanitaria de Santiago (IDIS), Hospital Clínico Universitario de Santiago (SERGAS) , Galicia , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, of the Instituto de Investigación Sanitaria de Santiago (IDIS), Hospital Clínico Universitario de Santiago (SERGAS) , Galicia </wicri:regionArea>
<orgName type="university">Université de Saint-Jacques-de-Compostelle</orgName>
<placeName><settlement type="city">Santiago de Compostela</settlement>
<region nuts="2" type="region">Galice</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Martin, Carlos" sort="Martin, Carlos" uniqKey="Martin C" first="Carlos" last="Martín">Carlos Martín</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine, Microbiology Department, University of Zaragoza , Zaragoza , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Faculty of Medicine, Microbiology Department, University of Zaragoza , Zaragoza </wicri:regionArea>
<wicri:noRegion>Zaragoza </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>CIBER of Respiratory Diseases, Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER of Respiratory Diseases, Instituto de Salud Carlos III , Madrid </wicri:regionArea>
<wicri:noRegion>Madrid </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Finn, Adam" sort="Finn, Adam" uniqKey="Finn A" first="Adam" last="Finn">Adam Finn</name>
<affiliation wicri:level="1"><nlm:affiliation>Bristol Children's Vaccine Centre, Schools of Cellular and Molecular Medicine and Population Health Sciences, University of Bristol , Bristol , UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Bristol Children's Vaccine Centre, Schools of Cellular and Molecular Medicine and Population Health Sciences, University of Bristol , Bristol </wicri:regionArea>
<wicri:noRegion>Bristol </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Butler, Robb" sort="Butler, Robb" uniqKey="Butler R" first="Robb" last="Butler">Robb Butler</name>
<affiliation wicri:level="2"><nlm:affiliation>UNICEF , New York , NY , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>UNICEF , New York , NY </wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31158041</idno>
<idno type="pmid">31158041</idno>
<idno type="doi">10.1080/21645515.2019.1609823</idno>
<idno type="pmc">PMC6816368</idno>
<idno type="wicri:Area/Main/Corpus">00015</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00015</idno>
<idno type="wicri:Area/Main/Curation">000015</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000015</idno>
<idno type="wicri:Area/Main/Exploration">000015</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">TIPICO IX: report of the 9<sup>th</sup>
 interactive infectious disease workshop on infectious diseases and vaccines.</title>
<author><name sortKey="Martin N Torres, Federico" sort="Martin N Torres, Federico" uniqKey="Martin N Torres F" first="Federico" last="Martin N-Torres">Federico Martin N-Torres</name>
<affiliation wicri:level="1"><nlm:affiliation>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bosch, Xavier" sort="Bosch, Xavier" uniqKey="Bosch X" first="Xavier" last="Bosch">Xavier Bosch</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Epidemiology Research Programme (e-oncología), Catalan Institute of Oncology, L'Hospitalet de Llobregat , Barcelona , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Cancer Epidemiology Research Programme (e-oncología), Catalan Institute of Oncology, L'Hospitalet de Llobregat , Barcelona </wicri:regionArea>
<wicri:noRegion>Barcelona </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat , Barcelona , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat , Barcelona </wicri:regionArea>
<wicri:noRegion>Barcelona </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rappuoli, Rino" sort="Rappuoli, Rino" uniqKey="Rappuoli R" first="Rino" last="Rappuoli">Rino Rappuoli</name>
<affiliation wicri:level="1"><nlm:affiliation>R&D Centre, GlaxoSmithKline , Siena , Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>R&D Centre, GlaxoSmithKline , Siena </wicri:regionArea>
<wicri:noRegion>Siena </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Imperial College London , London , UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Medicine, Imperial College London , London </wicri:regionArea>
<wicri:noRegion>London </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ladhani, Shamez" sort="Ladhani, Shamez" uniqKey="Ladhani S" first="Shamez" last="Ladhani">Shamez Ladhani</name>
<affiliation wicri:level="1"><nlm:affiliation>Immunisation Department, Public Health England , London , UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Immunisation Department, Public Health England , London </wicri:regionArea>
<wicri:noRegion>London </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Redondo, Esther" sort="Redondo, Esther" uniqKey="Redondo E" first="Esther" last="Redondo">Esther Redondo</name>
<affiliation wicri:level="1"><nlm:affiliation>International Vaccination Center of Madrid , Madrid , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>International Vaccination Center of Madrid , Madrid </wicri:regionArea>
<wicri:noRegion>Madrid </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Grupo de Actividades Preventivas y Salud Pública SEMERGEN , Madrid , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Grupo de Actividades Preventivas y Salud Pública SEMERGEN , Madrid </wicri:regionArea>
<wicri:noRegion>Madrid </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vesikari, Timo" sort="Vesikari, Timo" uniqKey="Vesikari T" first="Timo" last="Vesikari">Timo Vesikari</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine and Life Sciences, Vaccine Research Center, University of Tampere , Tampere , Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Faculty of Medicine and Life Sciences, Vaccine Research Center, University of Tampere , Tampere </wicri:regionArea>
<wicri:noRegion>Tampere </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Garcia Sastre, Adolfo" sort="Garcia Sastre, Adolfo" uniqKey="Garcia Sastre A" first="Adolfo" last="García-Sastre">Adolfo García-Sastre</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York , NY , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York , NY </wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai , New York , NY , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai , New York , NY </wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai , New York , NY , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai , New York , NY </wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rivero Calle, Irene" sort="Rivero Calle, Irene" uniqKey="Rivero Calle I" first="Irene" last="Rivero-Calle">Irene Rivero-Calle</name>
<affiliation wicri:level="1"><nlm:affiliation>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="G Mez Rial, Jose" sort="G Mez Rial, Jose" uniqKey="G Mez Rial J" first="José" last="G Mez-Rial">José G Mez-Rial</name>
<affiliation wicri:level="1"><nlm:affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Salas, Antonio" sort="Salas, Antonio" uniqKey="Salas A" first="Antonio" last="Salas">Antonio Salas</name>
<affiliation wicri:level="1"><nlm:affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela </wicri:regionArea>
<wicri:noRegion>Santiago de Compostela </wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, of the Instituto de Investigación Sanitaria de Santiago (IDIS), Hospital Clínico Universitario de Santiago (SERGAS) , Galicia , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, of the Instituto de Investigación Sanitaria de Santiago (IDIS), Hospital Clínico Universitario de Santiago (SERGAS) , Galicia </wicri:regionArea>
<orgName type="university">Université de Saint-Jacques-de-Compostelle</orgName>
<placeName><settlement type="city">Santiago de Compostela</settlement>
<region nuts="2" type="region">Galice</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Martin, Carlos" sort="Martin, Carlos" uniqKey="Martin C" first="Carlos" last="Martín">Carlos Martín</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine, Microbiology Department, University of Zaragoza , Zaragoza , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Faculty of Medicine, Microbiology Department, University of Zaragoza , Zaragoza </wicri:regionArea>
<wicri:noRegion>Zaragoza </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>CIBER of Respiratory Diseases, Instituto de Salud Carlos III , Madrid , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER of Respiratory Diseases, Instituto de Salud Carlos III , Madrid </wicri:regionArea>
<wicri:noRegion>Madrid </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Finn, Adam" sort="Finn, Adam" uniqKey="Finn A" first="Adam" last="Finn">Adam Finn</name>
<affiliation wicri:level="1"><nlm:affiliation>Bristol Children's Vaccine Centre, Schools of Cellular and Molecular Medicine and Population Health Sciences, University of Bristol , Bristol , UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Bristol Children's Vaccine Centre, Schools of Cellular and Molecular Medicine and Population Health Sciences, University of Bristol , Bristol </wicri:regionArea>
<wicri:noRegion>Bristol </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Butler, Robb" sort="Butler, Robb" uniqKey="Butler R" first="Robb" last="Butler">Robb Butler</name>
<affiliation wicri:level="2"><nlm:affiliation>UNICEF , New York , NY , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>UNICEF , New York , NY </wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Human vaccines & immunotherapeutics</title>
<idno type="eISSN">2164-554X</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clinical Trials as Topic (MeSH)</term>
<term>Communicable Disease Control (MeSH)</term>
<term>Communicable Diseases (parasitology)</term>
<term>Communicable Diseases (virology)</term>
<term>Congresses as Topic (MeSH)</term>
<term>Health Personnel (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Spain (MeSH)</term>
<term>Vaccines (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Congrès comme sujet (MeSH)</term>
<term>Contrôle des maladies transmissibles (MeSH)</term>
<term>Espagne (MeSH)</term>
<term>Essais cliniques comme sujet (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Maladies transmissibles (parasitologie)</term>
<term>Maladies transmissibles (virologie)</term>
<term>Personnel de santé (MeSH)</term>
<term>Vaccins (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Maladies transmissibles</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Communicable Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Maladies transmissibles</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Communicable Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Communicable Disease Control</term>
<term>Congresses as Topic</term>
<term>Health Personnel</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Congrès comme sujet</term>
<term>Contrôle des maladies transmissibles</term>
<term>Espagne</term>
<term>Essais cliniques comme sujet</term>
<term>Humains</term>
<term>Personnel de santé</term>
<term>Vaccins</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22-23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31158041</PMID>
<DateCompleted><Year>2020</Year>
<Month>02</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>02</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>15</Volume>
<Issue>10</Issue>
<PubDate><Year>2019</Year>
</PubDate>
</JournalIssue>
<Title>Human vaccines & immunotherapeutics</Title>
<ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
</Journal>
<ArticleTitle>TIPICO IX: report of the 9<sup>th</sup>
 interactive infectious disease workshop on infectious diseases and vaccines.</ArticleTitle>
<Pagination><MedlinePgn>2405-2415</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2019.1609823</ELocationID>
<Abstract><AbstractText>The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22-23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martinón-Torres</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">0000-0002-9023-581X</Identifier>
<AffiliationInfo><Affiliation>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela , Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bosch</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
<AffiliationInfo><Affiliation>Cancer Epidemiology Research Programme (e-oncología), Catalan Institute of Oncology, L'Hospitalet de Llobregat , Barcelona , Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat , Barcelona , Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rappuoli</LastName>
<ForeName>Rino</ForeName>
<Initials>R</Initials>
<Identifier Source="ORCID">0000-0002-8827-254X</Identifier>
<AffiliationInfo><Affiliation>R&D Centre, GlaxoSmithKline , Siena , Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Medicine, Imperial College London , London , UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ladhani</LastName>
<ForeName>Shamez</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Immunisation Department, Public Health England , London , UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Redondo</LastName>
<ForeName>Esther</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>International Vaccination Center of Madrid , Madrid , Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Grupo de Actividades Preventivas y Salud Pública SEMERGEN , Madrid , Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vesikari</LastName>
<ForeName>Timo</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Faculty of Medicine and Life Sciences, Vaccine Research Center, University of Tampere , Tampere , Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>García-Sastre</LastName>
<ForeName>Adolfo</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York , NY , USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai , New York , NY , USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai , New York , NY , USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rivero-Calle</LastName>
<ForeName>Irene</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela , Santiago de Compostela , Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gómez-Rial</LastName>
<ForeName>José</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Salas</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Genetics, Vaccines and Infections Research group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela , Santiago de Compostela , Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, of the Instituto de Investigación Sanitaria de Santiago (IDIS), Hospital Clínico Universitario de Santiago (SERGAS) , Galicia , Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Martín</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">0000-0003-2993-5478</Identifier>
<AffiliationInfo><Affiliation>Faculty of Medicine, Microbiology Department, University of Zaragoza , Zaragoza , Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>CIBER of Respiratory Diseases, Instituto de Salud Carlos III , Madrid , Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Finn</LastName>
<ForeName>Adam</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Bristol Children's Vaccine Centre, Schools of Cellular and Molecular Medicine and Population Health Sciences, University of Bristol , Bristol , UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Butler</LastName>
<ForeName>Robb</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>UNICEF , New York , NY , USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2019</Year>
<Month>06</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Hum Vaccin Immunother</MedlineTA>
<NlmUniqueID>101572652</NlmUniqueID>
<ISSNLinking>2164-5515</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003140" MajorTopicYN="Y">Communicable Disease Control</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003226" MajorTopicYN="N">Congresses as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">TIPICO</Keyword>
<Keyword MajorTopicYN="Y">infectious diseases</Keyword>
<Keyword MajorTopicYN="Y">infectomics</Keyword>
<Keyword MajorTopicYN="Y">vaccine hesitancy</Keyword>
<Keyword MajorTopicYN="Y">vaccines</Keyword>
<Keyword MajorTopicYN="Y">vaccinomics</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>2</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2019</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">31158041</ArticleId>
<ArticleId IdType="doi">10.1080/21645515.2019.1609823</ArticleId>
<ArticleId IdType="pmc">PMC6816368</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Vaccine. 2012 Jun 19;30(29):4301-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22682286</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Immunol. 2002 Feb;14(1):111-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11790540</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2000 Feb;181 Suppl 1:S228-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10657219</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Vaccine Res. 2017 Jan;6(1):4-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28168168</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull World Health Organ. 1993;71(5):549-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8261558</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pediatr. 2010 Nov;169(11):1379-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20559656</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2014 Dec 1;210(11):1772-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24939906</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2018 May 25;13(5):e0195799</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29799839</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2009 Jan;81(1):6-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18796313</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychol Sci Public Interest. 2012 Dec;13(3):106-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26173286</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Biotechnol. 2016 Apr;34(4):276-290</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26806111</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2015 May;15(5):535-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25801458</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2018 May 23;8(1):8043</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29795312</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2016 Nov 10;21(45):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27918265</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2011 Nov 04;11(12):865-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22051890</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2017 Jan 18;91(3):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27881649</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 2016 Feb;137(2):e20152848</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26791970</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2015 Jun 26;33(29):3314-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26026378</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Dis Child. 2017 Nov;102(11):1077-1081</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28501809</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Drug Resist. 2019 Apr 29;12:989-991</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31118704</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1992 Aug 6;358(6386):507-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1386410</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2019 May 31;37(25):3362-3368</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31064673</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2008;3(10):e3496</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18946503</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Funct Integr Genomics. 2002 Apr;1(6):331-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11957108</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Immunol. 2014 Jan 23;5:12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24478777</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2013 Jul;57(1):13-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23487388</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2016 Nov 02;6:35842</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27805046</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2015 Mar 19;372(12):1114-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25785969</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2016 Aug 23-30;316(8):835-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27552617</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tuberculosis (Edinb). 2016 Jan;96:71-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26786657</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Allergol Immunopathol (Madr). 2018 Jan - Feb;46(1):99-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28495398</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2016 Jan 15;213(2):243-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26232438</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2012 Jan;67(1):71-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20729232</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2015 Jan 15;60(2):228-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25301212</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2016 Nov 17;21(46):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27918268</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pathogens. 2017 Dec 12;6(4):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29231855</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Glob Health. 2018 Sep;6(9):e1036-e1044</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30103981</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2016 Dec 3;388(10061):2775-2782</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28100432</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Chemother. 2017 Jul;23(7):419-426</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28511987</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Dis Ther. 2016 Mar;5(1):31-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26721823</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2017 Sep 1;216(5):525-533</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28329234</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):125-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24344259</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Genet Evol. 2016 Oct;44:403-411</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27491455</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2018 Oct 30;67(10):1498-1506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29790925</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 2010 Oct 29;33(4):530-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21029963</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24927560</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pediatr. 2016 Aug;175(8):1023-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27156106</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Drug Resist. 2018 Dec 24;12:55-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30636886</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pediatr. 2018 Oct;177(10):1523-1529</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30022279</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2014 Jan;58(2):181-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24149079</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2016 Nov 7;16(1):645</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27821085</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>OMICS. 2011 Sep;15(9):625-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21732819</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2015 Aug 14;33(34):4176-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25896376</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Virol. 2013 Oct;3(5):521-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23978327</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 1996 Jul;77 ( Pt 7):1483-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8757990</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2014 Aug 14;5:4649</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25120092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2017 Feb 1;35(5):716-721</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28065475</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1996 Apr 1;183(4):1623-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8666920</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2017 Jul 14;8:16085</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28706226</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Inst Pasteur Madagascar. 1981;48(1):269-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7044329</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Public Health. 2019 Jan;4(1):e19-e27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30291040</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2018 Jan 19;15(1):17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29370862</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2017 Sep 18;35(39):5264-5270</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28823622</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2018 Aug 6;36(32 Pt A):4774-4782</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29366703</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2018 May 9;23(5):672-685.e6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29746837</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2018 May;37(5):475-482</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29329168</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Dis (Lond). 2017 May;49(5):388-395</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28067093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 Dec;86(24):13434-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23015722</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2017 Nov 21;7(1):15888</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29162850</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2015 Sep;21(9):1065-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26301691</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2018 Feb;18(2):171-179</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29174323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Genet. 2010 Sep;42(9):772-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20694013</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Am Thorac Soc. 2014 Aug;11 Suppl 4:S189-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25148424</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pediatr. 2015 Jul;174(7):919-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25573462</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2015 Jun 1;60(11):1611-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25725054</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2018 Aug;18(8):828-829</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30064668</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Glob Health. 2016 Jul;4(7):e453-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27340003</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Immunol. 2017 Sep 13;8:1134</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28955344</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2017 Nov 03;66(43):1192-1196</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29095805</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2012 Sep 13;12:213</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22974466</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2010 May 18;1(1):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20689752</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2015 Dec;3(12):953-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26598141</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Enferm Infecc Microbiol Clin. 2018 Dec;36(10):648-656</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29627126</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2017 Oct 28;492(4):587-596</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28576494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Psychol. 2013 Feb;32(2):146-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22409264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2015 Sep 18;349(6254):1301-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26303961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2014 Oct;69(4):326-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24887614</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22988082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Negl Trop Dis. 2015 Nov 06;9(11):e0004177</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26545242</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2012 Jul 13;12(8):581-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22790178</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2014 Sep;14(9):839-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25042756</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Pediatr. 2018 Oct 1;172(10):958-965</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30105384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2015 Feb 15;60(4):578-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25389259</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Genes (Basel). 2018 May 03;9(5):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29751582</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Psychol. 2013 Apr;32(4):361-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22059622</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2018 Oct 25;379(17):1621-1634</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30280651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2015 Jul 4;386(9988):31-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25913272</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Microbiol. 2017 Mar 01;8:257</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28298902</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2013 Oct 1;31(42):4867-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23965219</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Public Health. 2013 Dec;41(8):860-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23873631</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Res Immunol. 1993 Mar-Apr;144(3):209-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8235045</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2016 Apr 4;213(4):469-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27022144</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Virol. 2014 Apr;5:98-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24727707</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2014 Dec 5;32(51):6870-6879</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25444813</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2015 Jul 8;18(1):61-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26159719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2016 May 12;21(19):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27195770</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1981 Jan 30;211(4481):453-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7455683</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
<li>Finlande</li>
<li>Italie</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Galice</li>
<li>État de New York</li>
</region>
<settlement><li>Santiago de Compostela</li>
</settlement>
<orgName><li>Université de Saint-Jacques-de-Compostelle</li>
</orgName>
</list>
<tree><country name="Espagne"><noRegion><name sortKey="Martin N Torres, Federico" sort="Martin N Torres, Federico" uniqKey="Martin N Torres F" first="Federico" last="Martin N-Torres">Federico Martin N-Torres</name>
</noRegion>
<name sortKey="Bosch, Xavier" sort="Bosch, Xavier" uniqKey="Bosch X" first="Xavier" last="Bosch">Xavier Bosch</name>
<name sortKey="Bosch, Xavier" sort="Bosch, Xavier" uniqKey="Bosch X" first="Xavier" last="Bosch">Xavier Bosch</name>
<name sortKey="G Mez Rial, Jose" sort="G Mez Rial, Jose" uniqKey="G Mez Rial J" first="José" last="G Mez-Rial">José G Mez-Rial</name>
<name sortKey="Martin N Torres, Federico" sort="Martin N Torres, Federico" uniqKey="Martin N Torres F" first="Federico" last="Martin N-Torres">Federico Martin N-Torres</name>
<name sortKey="Martin, Carlos" sort="Martin, Carlos" uniqKey="Martin C" first="Carlos" last="Martín">Carlos Martín</name>
<name sortKey="Martin, Carlos" sort="Martin, Carlos" uniqKey="Martin C" first="Carlos" last="Martín">Carlos Martín</name>
<name sortKey="Redondo, Esther" sort="Redondo, Esther" uniqKey="Redondo E" first="Esther" last="Redondo">Esther Redondo</name>
<name sortKey="Redondo, Esther" sort="Redondo, Esther" uniqKey="Redondo E" first="Esther" last="Redondo">Esther Redondo</name>
<name sortKey="Rivero Calle, Irene" sort="Rivero Calle, Irene" uniqKey="Rivero Calle I" first="Irene" last="Rivero-Calle">Irene Rivero-Calle</name>
<name sortKey="Rivero Calle, Irene" sort="Rivero Calle, Irene" uniqKey="Rivero Calle I" first="Irene" last="Rivero-Calle">Irene Rivero-Calle</name>
<name sortKey="Salas, Antonio" sort="Salas, Antonio" uniqKey="Salas A" first="Antonio" last="Salas">Antonio Salas</name>
<name sortKey="Salas, Antonio" sort="Salas, Antonio" uniqKey="Salas A" first="Antonio" last="Salas">Antonio Salas</name>
</country>
<country name="Italie"><noRegion><name sortKey="Rappuoli, Rino" sort="Rappuoli, Rino" uniqKey="Rappuoli R" first="Rino" last="Rappuoli">Rino Rappuoli</name>
</noRegion>
</country>
<country name="Royaume-Uni"><noRegion><name sortKey="Rappuoli, Rino" sort="Rappuoli, Rino" uniqKey="Rappuoli R" first="Rino" last="Rappuoli">Rino Rappuoli</name>
</noRegion>
<name sortKey="Finn, Adam" sort="Finn, Adam" uniqKey="Finn A" first="Adam" last="Finn">Adam Finn</name>
<name sortKey="Ladhani, Shamez" sort="Ladhani, Shamez" uniqKey="Ladhani S" first="Shamez" last="Ladhani">Shamez Ladhani</name>
</country>
<country name="Finlande"><noRegion><name sortKey="Vesikari, Timo" sort="Vesikari, Timo" uniqKey="Vesikari T" first="Timo" last="Vesikari">Timo Vesikari</name>
</noRegion>
</country>
<country name="États-Unis"><region name="État de New York"><name sortKey="Garcia Sastre, Adolfo" sort="Garcia Sastre, Adolfo" uniqKey="Garcia Sastre A" first="Adolfo" last="García-Sastre">Adolfo García-Sastre</name>
</region>
<name sortKey="Butler, Robb" sort="Butler, Robb" uniqKey="Butler R" first="Robb" last="Butler">Robb Butler</name>
<name sortKey="Garcia Sastre, Adolfo" sort="Garcia Sastre, Adolfo" uniqKey="Garcia Sastre A" first="Adolfo" last="García-Sastre">Adolfo García-Sastre</name>
<name sortKey="Garcia Sastre, Adolfo" sort="Garcia Sastre, Adolfo" uniqKey="Garcia Sastre A" first="Adolfo" last="García-Sastre">Adolfo García-Sastre</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000018 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000018 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31158041
   |texte=   TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31158041" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021

	Serveur d'exploration sur la grippe en Espagne
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe en Espagne

TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines.

TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki